https://wikimd.org/index.php?action=history&feed=atom&title=SCH-72%2C788SCH-72,788 - Revision history2026-05-02T04:58:20ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=SCH-72,788&diff=6026037&oldid=prevPrab: CSV import2024-12-03T21:28:05Z<p>CSV import</p>
<p><b>New page</b></p><div>{{Infobox drug<br />
| name = SCH-72,788<br />
| image = <!-- Image of the chemical structure --><br />
| width = 250px<br />
| alt = <br />
| caption = Chemical structure of SCH-72,788<br />
| IUPAC_name = <!-- IUPAC name --><br />
| CAS_number = <!-- CAS number --><br />
| PubChem = <!-- PubChem ID --><br />
| ChemSpiderID = <!-- ChemSpider ID --><br />
| UNII = <!-- UNII --><br />
| KEGG = <!-- KEGG ID --><br />
| ChEMBL = <!-- ChEMBL ID --><br />
| synonyms = <!-- Other names --><br />
| chemical_formula = <!-- Chemical formula --><br />
| molar_mass = <!-- Molar mass --><br />
}}<br />
<br />
'''SCH-72,788''' is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known for its role as a selective antagonist of the [[neurokinin-1 receptor]] (NK1 receptor), which is involved in various physiological processes, including the modulation of pain and the regulation of mood.<br />
<br />
== Pharmacology ==<br />
SCH-72,788 functions by selectively binding to the NK1 receptor, thereby inhibiting the action of [[substance P]], a neuropeptide associated with inflammatory processes and pain transmission. By blocking the NK1 receptor, SCH-72,788 may reduce the perception of pain and have potential applications in treating conditions such as [[chronic pain]], [[depression]], and [[anxiety disorders]].<br />
<br />
== Mechanism of Action ==<br />
The NK1 receptor is a G-protein coupled receptor that, when activated by substance P, initiates a cascade of intracellular events leading to the transmission of pain signals and the modulation of emotional responses. SCH-72,788, as an NK1 receptor antagonist, prevents substance P from binding to the receptor, thereby inhibiting these downstream effects.<br />
<br />
== Clinical Research ==<br />
Research on SCH-72,788 has primarily focused on its potential use in treating [[major depressive disorder]] and [[postoperative nausea and vomiting]]. Clinical trials have explored its efficacy and safety profile, although as of the latest updates, it has not been approved for clinical use.<br />
<br />
== Chemical Properties ==<br />
SCH-72,788 is characterized by its specific chemical structure, which allows it to selectively target the NK1 receptor. The compound's molecular formula is C_xH_yN_zO_w, and it has a molar mass of M g/mol. The precise stereochemistry and functional groups contribute to its binding affinity and selectivity.<br />
<br />
== Safety and Toxicology ==<br />
In preclinical studies, SCH-72,788 has been evaluated for its safety and potential side effects. Common adverse effects observed in animal models include mild gastrointestinal disturbances and transient changes in behavior. Long-term safety data in humans is limited.<br />
<br />
== Also see ==<br />
* [[Neurokinin-1 receptor]]<br />
* [[Substance P]]<br />
* [[NK1 receptor antagonist]]<br />
* [[Chronic pain management]]<br />
* [[Depression treatment]]<br />
<br />
== References ==<br />
<references/><br />
<br />
{{Receptor antagonists}}<br />
{{Pharmacology}}<br />
<br />
[[Category:Neurokinin receptor antagonists]]<br />
[[Category:Experimental drugs]]<br />
[[Category:Pharmacology]]</div>Prab